Top Banner
Bariatric Surgery and Metabolism • Goal: to review 4 important and clinically relevant papers from 2010 on Bariatric Surgery and Metabolism 03/22/22 1
47

Bariatric Surgery and Metabolism Goal: to review 4 important and clinically relevant papers from 2010 on Bariatric Surgery and Metabolism 10/10/20151.

Dec 30, 2015

Download

Documents

Melissa Doyle
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Bariatric Surgery and Metabolism Goal: to review 4 important and clinically relevant papers from 2010 on Bariatric Surgery and Metabolism 10/10/20151.

Bariatric Surgery and Metabolism

• Goal: to review 4 important and clinically relevant papers from 2010 on Bariatric Surgery and Metabolism

04/19/23 1

Page 2: Bariatric Surgery and Metabolism Goal: to review 4 important and clinically relevant papers from 2010 on Bariatric Surgery and Metabolism 10/10/20151.

Disclosures

1. I am still pissed we’re not at Vail.

2. Ethicon: Advisory board

Page 3: Bariatric Surgery and Metabolism Goal: to review 4 important and clinically relevant papers from 2010 on Bariatric Surgery and Metabolism 10/10/20151.

Whistler 2004

Page 4: Bariatric Surgery and Metabolism Goal: to review 4 important and clinically relevant papers from 2010 on Bariatric Surgery and Metabolism 10/10/20151.
Page 5: Bariatric Surgery and Metabolism Goal: to review 4 important and clinically relevant papers from 2010 on Bariatric Surgery and Metabolism 10/10/20151.

Objective

• Metabolic surgery to treat type 2 diabetes mellitus in patients who do not meet body weight criteria for morbid obesity (BMI 30-35)

• Comparing LRYGB and LAGB in this patient population

Page 6: Bariatric Surgery and Metabolism Goal: to review 4 important and clinically relevant papers from 2010 on Bariatric Surgery and Metabolism 10/10/20151.

Methods

• Bariatric Outcomes Longitudinal Database (BOLD)

• 66264 bariatric procedures• 794 with BMI 30-35 kg/m2

• 235 with diabetes requiring medication• 109 LAGB ; 109 LRYGB• 92% Laparoscopic

Page 7: Bariatric Surgery and Metabolism Goal: to review 4 important and clinically relevant papers from 2010 on Bariatric Surgery and Metabolism 10/10/20151.

Results

More severe DM in bypass group

More complications in bypass group

Page 8: Bariatric Surgery and Metabolism Goal: to review 4 important and clinically relevant papers from 2010 on Bariatric Surgery and Metabolism 10/10/20151.

Results

• Both procedures resulted in significant decrease in BMI, DM severity and # of DM medications

• Gastric bypass showed better results than gastric band

Page 9: Bariatric Surgery and Metabolism Goal: to review 4 important and clinically relevant papers from 2010 on Bariatric Surgery and Metabolism 10/10/20151.

Results

# DM Meds.BMI

Page 10: Bariatric Surgery and Metabolism Goal: to review 4 important and clinically relevant papers from 2010 on Bariatric Surgery and Metabolism 10/10/20151.

Results

Page 11: Bariatric Surgery and Metabolism Goal: to review 4 important and clinically relevant papers from 2010 on Bariatric Surgery and Metabolism 10/10/20151.

Conclusion

• Both LAGB and LRYGB achieve significant, favorable impact on type 2 diabetes in the moderately obese (BMI 30-35)

• Both procedures demonstrate a significant reduction in diabetes co-morbidity score and # of diabetes medication

• Gastric bypass provides more effective treatment at the price of higher complication rates (mostly minor)

Page 12: Bariatric Surgery and Metabolism Goal: to review 4 important and clinically relevant papers from 2010 on Bariatric Surgery and Metabolism 10/10/20151.
Page 13: Bariatric Surgery and Metabolism Goal: to review 4 important and clinically relevant papers from 2010 on Bariatric Surgery and Metabolism 10/10/20151.

Objective

• Evaluation of bariatric surgery as secondary prevention in obese patients with ischemic heart disease (IHD)

Page 14: Bariatric Surgery and Metabolism Goal: to review 4 important and clinically relevant papers from 2010 on Bariatric Surgery and Metabolism 10/10/20151.

Methods

• 4047 subjects in the Swedish Obese Subjects (SOS) group

• 35 with IHD• 21 treated with bariatric surgery ; 14 treated

conventionally• Mean follow-up 10.8 years

Page 15: Bariatric Surgery and Metabolism Goal: to review 4 important and clinically relevant papers from 2010 on Bariatric Surgery and Metabolism 10/10/20151.

Methods

• SOS study:

Page 16: Bariatric Surgery and Metabolism Goal: to review 4 important and clinically relevant papers from 2010 on Bariatric Surgery and Metabolism 10/10/20151.

Results

Mean weight change

At 2 and 10 years bariatric surgery resulted in significantly greater weight loss compared to the control group

Page 17: Bariatric Surgery and Metabolism Goal: to review 4 important and clinically relevant papers from 2010 on Bariatric Surgery and Metabolism 10/10/20151.

Results

Page 18: Bariatric Surgery and Metabolism Goal: to review 4 important and clinically relevant papers from 2010 on Bariatric Surgery and Metabolism 10/10/20151.

Results

Page 19: Bariatric Surgery and Metabolism Goal: to review 4 important and clinically relevant papers from 2010 on Bariatric Surgery and Metabolism 10/10/20151.

Results

Page 20: Bariatric Surgery and Metabolism Goal: to review 4 important and clinically relevant papers from 2010 on Bariatric Surgery and Metabolism 10/10/20151.

Conclusion

• Bariatric surgery appears to be a safe and feasible treatment to achieve long-term weight loss and improvement in cardio-vascular risk factors, symptoms and quality of life in obese subjects with IHD

Page 21: Bariatric Surgery and Metabolism Goal: to review 4 important and clinically relevant papers from 2010 on Bariatric Surgery and Metabolism 10/10/20151.
Page 22: Bariatric Surgery and Metabolism Goal: to review 4 important and clinically relevant papers from 2010 on Bariatric Surgery and Metabolism 10/10/20151.

Objective

• To present the longest follow-up report of any lipid-atherosclerosis interventional trial

Page 23: Bariatric Surgery and Metabolism Goal: to review 4 important and clinically relevant papers from 2010 on Bariatric Surgery and Metabolism 10/10/20151.

Methods

• 25 years of follow-up in the POSCH study:

Overall mortalitySpecific cause of deathPrediction for increase in life expectancy

Page 24: Bariatric Surgery and Metabolism Goal: to review 4 important and clinically relevant papers from 2010 on Bariatric Surgery and Metabolism 10/10/20151.

Results

Page 25: Bariatric Surgery and Metabolism Goal: to review 4 important and clinically relevant papers from 2010 on Bariatric Surgery and Metabolism 10/10/20151.

Results

Page 26: Bariatric Surgery and Metabolism Goal: to review 4 important and clinically relevant papers from 2010 on Bariatric Surgery and Metabolism 10/10/20151.

Results

Page 27: Bariatric Surgery and Metabolism Goal: to review 4 important and clinically relevant papers from 2010 on Bariatric Surgery and Metabolism 10/10/20151.

Results

Page 28: Bariatric Surgery and Metabolism Goal: to review 4 important and clinically relevant papers from 2010 on Bariatric Surgery and Metabolism 10/10/20151.

Conclusion

• A 25 year mortality follow-up in POSCH shows statistically significant gains in overall survival, cardio-vascular disease free survival and life expectancy in the surgery group compared to the controlled group

Page 29: Bariatric Surgery and Metabolism Goal: to review 4 important and clinically relevant papers from 2010 on Bariatric Surgery and Metabolism 10/10/20151.
Page 30: Bariatric Surgery and Metabolism Goal: to review 4 important and clinically relevant papers from 2010 on Bariatric Surgery and Metabolism 10/10/20151.

Objective

• To investigate the rate of type 2 diabetes remission after gastric bypass and banding and establish the mechanism leading to remission of type 2 diabetes after bariatric surgery

Page 31: Bariatric Surgery and Metabolism Goal: to review 4 important and clinically relevant papers from 2010 on Bariatric Surgery and Metabolism 10/10/20151.

• Study 1:

34 obese type 2 diabetics

Gastric bypass or banding

3 year follow-up

• Study 2

41 obese type 2 diabetics

Gastric bypass, banding orvery low calorie diet

42 day follow-up

Page 32: Bariatric Surgery and Metabolism Goal: to review 4 important and clinically relevant papers from 2010 on Bariatric Surgery and Metabolism 10/10/20151.

Results Study 1

Page 33: Bariatric Surgery and Metabolism Goal: to review 4 important and clinically relevant papers from 2010 on Bariatric Surgery and Metabolism 10/10/20151.

ResultsStudy 2

Page 34: Bariatric Surgery and Metabolism Goal: to review 4 important and clinically relevant papers from 2010 on Bariatric Surgery and Metabolism 10/10/20151.

ResultsStudy 2

Page 35: Bariatric Surgery and Metabolism Goal: to review 4 important and clinically relevant papers from 2010 on Bariatric Surgery and Metabolism 10/10/20151.

ResultsStudy 2

Page 36: Bariatric Surgery and Metabolism Goal: to review 4 important and clinically relevant papers from 2010 on Bariatric Surgery and Metabolism 10/10/20151.

Conclusion

Page 37: Bariatric Surgery and Metabolism Goal: to review 4 important and clinically relevant papers from 2010 on Bariatric Surgery and Metabolism 10/10/20151.
Page 38: Bariatric Surgery and Metabolism Goal: to review 4 important and clinically relevant papers from 2010 on Bariatric Surgery and Metabolism 10/10/20151.

Methods

• Trials comparing bariatric surgery vs. no surgery in patients with morbid obesity with the following end-points:

• Non-CV mortality• CV mortality• Global mortality – CV + non-CV

Page 39: Bariatric Surgery and Metabolism Goal: to review 4 important and clinically relevant papers from 2010 on Bariatric Surgery and Metabolism 10/10/20151.

Results

Small (<3000 pts.) vs.

Large (>3000 pts.)

Page 40: Bariatric Surgery and Metabolism Goal: to review 4 important and clinically relevant papers from 2010 on Bariatric Surgery and Metabolism 10/10/20151.

Results

LAGB

Vs.

RYGB

Page 41: Bariatric Surgery and Metabolism Goal: to review 4 important and clinically relevant papers from 2010 on Bariatric Surgery and Metabolism 10/10/20151.

Conclusion

• Bariatric surgery reduces the risk of global mortality, CV mortality and all-cause mortality compared to participants not undergoing surgery

• Risk reduction is lower in large studies than in small studies

• Both gastric bypass and gastric band seem to reduce mortality risk

Page 42: Bariatric Surgery and Metabolism Goal: to review 4 important and clinically relevant papers from 2010 on Bariatric Surgery and Metabolism 10/10/20151.

Bariatric surgery and metabolism

Other papers of interest

Page 43: Bariatric Surgery and Metabolism Goal: to review 4 important and clinically relevant papers from 2010 on Bariatric Surgery and Metabolism 10/10/20151.

04/19/23 43

Page 44: Bariatric Surgery and Metabolism Goal: to review 4 important and clinically relevant papers from 2010 on Bariatric Surgery and Metabolism 10/10/20151.
Page 45: Bariatric Surgery and Metabolism Goal: to review 4 important and clinically relevant papers from 2010 on Bariatric Surgery and Metabolism 10/10/20151.
Page 46: Bariatric Surgery and Metabolism Goal: to review 4 important and clinically relevant papers from 2010 on Bariatric Surgery and Metabolism 10/10/20151.

SUMMARY: Diabetes

Both restrictive (AGB) and malabsorptive (RGBP) procedures improve diabetic control

Improvement and remission of DM is significantly greater with malabsorptive (largely GBP), even with equivalent weight loss in some studies

Postprandial increase in GLP-1, insulin secretion and improvement in insulin resistance occurs only with GBP, even before weight loss; mechanisms (duodenal exclusion, incretin effects, neural, etc.) still incompletely explained

Restrictive and malabsorptive procedures both improve DM in patients with BMI <35, although less dramatically than in patients with BMI > 35

04/19/23 46

Page 47: Bariatric Surgery and Metabolism Goal: to review 4 important and clinically relevant papers from 2010 on Bariatric Surgery and Metabolism 10/10/20151.

SUMMARY: Mortality

Partial ileal bypass for hyperlipidemia improves 25 year survival, > in patients with baseline EF ≥ 50% (survival by 1.7 years; 100,000 less deaths per million patients at 25 years)

Reduced mortality after both AGB and GBP compared to controls (global and all-cause)

? Greater reduction in CV mortality with GBP reported in diabetics

Bariatric surgery can be performed safely in patients with IHD, but no reduction in CV events or deaths compared to controls (limitations of study: low BMI, small sample size, primarily restrictive procedures (VBG))

04/19/23 47